

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.23957857 |
| 2 | viral transcription (GO:0019083) | 6.03379667 |
| 3 | translational termination (GO:0006415) | 5.87682024 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 5.73404810 |
| 5 | ribosomal small subunit assembly (GO:0000028) | 5.70391283 |
| 6 | translational elongation (GO:0006414) | 5.22307930 |
| 7 | maturation of SSU-rRNA (GO:0030490) | 5.18322015 |
| 8 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.01027047 |
| 9 | protein targeting to ER (GO:0045047) | 4.87254712 |
| 10 | cotranslational protein targeting to membrane (GO:0006613) | 4.87028715 |
| 11 | translational initiation (GO:0006413) | 4.85350708 |
| 12 | nuclear pore complex assembly (GO:0051292) | 4.74548877 |
| 13 | ribosomal large subunit biogenesis (GO:0042273) | 4.65399559 |
| 14 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.65110959 |
| 15 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.63778472 |
| 16 | protein localization to endoplasmic reticulum (GO:0070972) | 4.61862551 |
| 17 | viral life cycle (GO:0019058) | 4.58264675 |
| 18 | cellular protein complex disassembly (GO:0043624) | 4.55876784 |
| 19 | formation of translation preinitiation complex (GO:0001731) | 4.41433992 |
| 20 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.41312526 |
| 21 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.30727649 |
| 22 | nuclear pore organization (GO:0006999) | 4.28793061 |
| 23 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.24214615 |
| 24 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.09730033 |
| 25 | DNA strand elongation (GO:0022616) | 4.03963149 |
| 26 | protein complex disassembly (GO:0043241) | 4.03928856 |
| 27 | ribosome assembly (GO:0042255) | 3.96145344 |
| 28 | ribosome biogenesis (GO:0042254) | 3.92597252 |
| 29 | regulation of translational fidelity (GO:0006450) | 3.89308455 |
| 30 | nucleobase biosynthetic process (GO:0046112) | 3.87661720 |
| 31 | DNA replication initiation (GO:0006270) | 3.84431119 |
| 32 | macromolecular complex disassembly (GO:0032984) | 3.83852910 |
| 33 | purine nucleobase biosynthetic process (GO:0009113) | 3.83154395 |
| 34 | rRNA processing (GO:0006364) | 3.81050505 |
| 35 | translation (GO:0006412) | 3.80892580 |
| 36 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.76864659 |
| 37 | mitotic chromosome condensation (GO:0007076) | 3.73147494 |
| 38 | rRNA metabolic process (GO:0016072) | 3.71742110 |
| 39 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.62302651 |
| 40 | pseudouridine synthesis (GO:0001522) | 3.58267607 |
| 41 | DNA replication checkpoint (GO:0000076) | 3.58189491 |
| 42 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.56788462 |
| 43 | negative regulation of RNA splicing (GO:0033119) | 3.53270607 |
| 44 | pore complex assembly (GO:0046931) | 3.49787993 |
| 45 | telomere maintenance via recombination (GO:0000722) | 3.47923815 |
| 46 | DNA unwinding involved in DNA replication (GO:0006268) | 3.47788786 |
| 47 | cellular component biogenesis (GO:0044085) | 3.43447664 |
| 48 | mRNA catabolic process (GO:0006402) | 3.42443453 |
| 49 | DNA topological change (GO:0006265) | 3.42339485 |
| 50 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.41931846 |
| 51 | folic acid metabolic process (GO:0046655) | 3.41625610 |
| 52 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.40565881 |
| 53 | proteasome assembly (GO:0043248) | 3.37207870 |
| 54 | heterochromatin organization (GO:0070828) | 3.36933901 |
| 55 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.35917665 |
| 56 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.35917665 |
| 57 | spliceosomal snRNP assembly (GO:0000387) | 3.35049022 |
| 58 | RNA catabolic process (GO:0006401) | 3.35033634 |
| 59 | establishment of integrated proviral latency (GO:0075713) | 3.33741212 |
| 60 | oxidative phosphorylation (GO:0006119) | 3.30605494 |
| 61 | proline biosynthetic process (GO:0006561) | 3.28432687 |
| 62 | mitotic recombination (GO:0006312) | 3.25578062 |
| 63 | IMP biosynthetic process (GO:0006188) | 3.24464916 |
| 64 | ncRNA 3-end processing (GO:0043628) | 3.23893770 |
| 65 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.19189489 |
| 66 | rRNA modification (GO:0000154) | 3.18221381 |
| 67 | transcription from mitochondrial promoter (GO:0006390) | 3.18108728 |
| 68 | protein targeting to membrane (GO:0006612) | 3.15813284 |
| 69 | negative regulation of mRNA processing (GO:0050686) | 3.13791587 |
| 70 | mitotic metaphase plate congression (GO:0007080) | 3.12253844 |
| 71 | protein localization to kinetochore (GO:0034501) | 3.11382025 |
| 72 | telomere maintenance via telomere lengthening (GO:0010833) | 3.09725881 |
| 73 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.08054203 |
| 74 | chromatin remodeling at centromere (GO:0031055) | 3.06174713 |
| 75 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.02030933 |
| 76 | kinetochore organization (GO:0051383) | 3.00051078 |
| 77 | CENP-A containing nucleosome assembly (GO:0034080) | 2.98170523 |
| 78 | mitotic sister chromatid segregation (GO:0000070) | 2.97142094 |
| 79 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.96061863 |
| 80 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.92791731 |
| 81 | rRNA transcription (GO:0009303) | 2.92744797 |
| 82 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.92739873 |
| 83 | negative regulation of mRNA metabolic process (GO:1903312) | 2.92557672 |
| 84 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.91794051 |
| 85 | IMP metabolic process (GO:0046040) | 2.91612110 |
| 86 | peptidyl-histidine modification (GO:0018202) | 2.90932664 |
| 87 | mitotic nuclear envelope disassembly (GO:0007077) | 2.90140686 |
| 88 | viral mRNA export from host cell nucleus (GO:0046784) | 2.89781428 |
| 89 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.89104413 |
| 90 | termination of RNA polymerase III transcription (GO:0006386) | 2.89104413 |
| 91 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.89039676 |
| 92 | chromatin assembly or disassembly (GO:0006333) | 2.87814607 |
| 93 | DNA duplex unwinding (GO:0032508) | 2.87587588 |
| 94 | protein targeting to mitochondrion (GO:0006626) | 2.85827189 |
| 95 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.85774125 |
| 96 | DNA replication-independent nucleosome organization (GO:0034724) | 2.85774125 |
| 97 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.85150464 |
| 98 | negative regulation of ligase activity (GO:0051352) | 2.85150464 |
| 99 | sister chromatid segregation (GO:0000819) | 2.84769189 |
| 100 | termination of RNA polymerase II transcription (GO:0006369) | 2.82969936 |
| 101 | protein localization to chromosome, centromeric region (GO:0071459) | 2.81665171 |
| 102 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.81646777 |
| 103 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.80387539 |
| 104 | ncRNA processing (GO:0034470) | 2.80098217 |
| 105 | DNA geometric change (GO:0032392) | 2.79886887 |
| 106 | spliceosomal complex assembly (GO:0000245) | 2.79817832 |
| 107 | chromatin assembly (GO:0031497) | 2.78671561 |
| 108 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.78051108 |
| 109 | tRNA aminoacylation for protein translation (GO:0006418) | 2.74502151 |
| 110 | ncRNA metabolic process (GO:0034660) | 2.73266593 |
| 111 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.72112221 |
| 112 | mRNA splicing, via spliceosome (GO:0000398) | 2.72112221 |
| 113 | nuclear envelope disassembly (GO:0051081) | 2.71597189 |
| 114 | membrane disassembly (GO:0030397) | 2.71597189 |
| 115 | tRNA aminoacylation (GO:0043039) | 2.71282756 |
| 116 | amino acid activation (GO:0043038) | 2.71282756 |
| 117 | RNA splicing, via transesterification reactions (GO:0000375) | 2.71000454 |
| 118 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.70758254 |
| 119 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.70046307 |
| 120 | respiratory chain complex IV assembly (GO:0008535) | 2.69012155 |
| 121 | regulation of mitochondrial translation (GO:0070129) | 2.67817993 |
| 122 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.67751917 |
| 123 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.67335465 |
| 124 | isotype switching (GO:0045190) | 2.67335465 |
| 125 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.67335465 |
| 126 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.67252639 |
| 127 | metaphase plate congression (GO:0051310) | 2.66508119 |
| 128 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.63503660 |
| 129 | cell cycle G1/S phase transition (GO:0044843) | 2.63503660 |
| 130 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.63064890 |
| 131 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.62844573 |
| 132 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.62844573 |
| 133 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.62609087 |
| 134 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.61836213 |
| 135 | transcription from RNA polymerase I promoter (GO:0006360) | 2.61384030 |
| 136 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.61252124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.07395469 |
| 2 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.59670451 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.17523644 |
| 4 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.14199847 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.03298716 |
| 6 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.99992605 |
| 7 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.98144588 |
| 8 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.89779866 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.84889193 |
| 10 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.83244516 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.80806196 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.74602395 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.64437885 |
| 14 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.50306900 |
| 15 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.49097075 |
| 16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.47114364 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.30993646 |
| 18 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.27668261 |
| 19 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.26997071 |
| 20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.25397544 |
| 21 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.20974719 |
| 22 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.19640519 |
| 23 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.02179595 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.01068092 |
| 25 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.90170199 |
| 26 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.89252117 |
| 27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.87382220 |
| 28 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86780196 |
| 29 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.82400388 |
| 30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.80585970 |
| 31 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.79400154 |
| 32 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.76572955 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.73473886 |
| 34 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.72187741 |
| 35 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71338068 |
| 36 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.68814188 |
| 37 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.67571641 |
| 38 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.66258800 |
| 39 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64248906 |
| 40 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.63033152 |
| 41 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.62281571 |
| 42 | MYC_22102868_ChIP-Seq_BL_Human | 1.60234418 |
| 43 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.59952370 |
| 44 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.57450938 |
| 45 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.48959363 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48126425 |
| 47 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.47280993 |
| 48 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.41234790 |
| 49 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.40208520 |
| 50 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.39178060 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38804124 |
| 52 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.38642401 |
| 53 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.38479591 |
| 54 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.37423435 |
| 55 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.37030598 |
| 56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.36776425 |
| 57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35368876 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32897811 |
| 59 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.28847732 |
| 60 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.27779323 |
| 61 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.27249897 |
| 62 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.26571044 |
| 63 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24506852 |
| 64 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.23118817 |
| 65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21174528 |
| 66 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.19475912 |
| 67 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19355341 |
| 68 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19065235 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17658735 |
| 70 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17558497 |
| 71 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.17031278 |
| 72 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.16197950 |
| 73 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.15686241 |
| 74 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.15372693 |
| 75 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14525109 |
| 76 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12615160 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.12211479 |
| 78 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12140020 |
| 79 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11240398 |
| 80 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09717791 |
| 81 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.09568473 |
| 82 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.08470748 |
| 83 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07787216 |
| 84 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.05830000 |
| 85 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.05252505 |
| 86 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.02276267 |
| 87 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.02172851 |
| 88 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.01732976 |
| 89 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01593169 |
| 90 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01556477 |
| 91 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.99700664 |
| 92 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99132294 |
| 93 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98612552 |
| 94 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97164744 |
| 95 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.96901471 |
| 96 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.96620370 |
| 97 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95812287 |
| 98 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.95650544 |
| 99 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.95419071 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.95343123 |
| 101 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.95222155 |
| 102 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95123506 |
| 103 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.95114446 |
| 104 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93892947 |
| 105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92617870 |
| 106 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.91549475 |
| 107 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.91102008 |
| 108 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.90628301 |
| 109 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.90496123 |
| 110 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.85830755 |
| 111 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.85666229 |
| 112 | MAF_26560356_Chip-Seq_TH2_Human | 0.85119471 |
| 113 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.83444100 |
| 114 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82227162 |
| 115 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.81355545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0003693_abnormal_embryo_hatching | 5.06360507 |
| 2 | * MP0004957_abnormal_blastocyst_morpholog | 4.72254014 |
| 3 | MP0003111_abnormal_nucleus_morphology | 3.73662294 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.72871594 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.68558394 |
| 6 | MP0003077_abnormal_cell_cycle | 3.34825014 |
| 7 | MP0008007_abnormal_cellular_replicative | 2.56959647 |
| 8 | MP0008058_abnormal_DNA_repair | 2.56627204 |
| 9 | MP0000490_abnormal_crypts_of | 2.45733897 |
| 10 | MP0008932_abnormal_embryonic_tissue | 2.43822629 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.25403482 |
| 12 | MP0008057_abnormal_DNA_replication | 2.22244936 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.22190114 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.22169315 |
| 15 | MP0005451_abnormal_body_composition | 2.14135598 |
| 16 | * MP0001730_embryonic_growth_arrest | 2.13441923 |
| 17 | MP0000350_abnormal_cell_proliferation | 2.09815911 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.07998734 |
| 19 | MP0009697_abnormal_copulation | 1.97127316 |
| 20 | MP0004185_abnormal_adipocyte_glucose | 1.89376626 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 1.82738100 |
| 22 | MP0000678_abnormal_parathyroid_gland | 1.78727083 |
| 23 | MP0003123_paternal_imprinting | 1.77640792 |
| 24 | MP0003186_abnormal_redox_activity | 1.76063602 |
| 25 | MP0003786_premature_aging | 1.75806384 |
| 26 | MP0003718_maternal_effect | 1.64067225 |
| 27 | MP0002163_abnormal_gland_morphology | 1.61379472 |
| 28 | MP0001697_abnormal_embryo_size | 1.59630259 |
| 29 | * MP0002080_prenatal_lethality | 1.52781917 |
| 30 | MP0010307_abnormal_tumor_latency | 1.51171184 |
| 31 | MP0002019_abnormal_tumor_incidence | 1.44902470 |
| 32 | * MP0001672_abnormal_embryogenesis/_devel | 1.44493422 |
| 33 | * MP0005380_embryogenesis_phenotype | 1.44493422 |
| 34 | MP0000313_abnormal_cell_death | 1.41161840 |
| 35 | MP0006036_abnormal_mitochondrial_physio | 1.40597829 |
| 36 | MP0001188_hyperpigmentation | 1.39754194 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.38079730 |
| 38 | MP0009840_abnormal_foam_cell | 1.35602427 |
| 39 | MP0002086_abnormal_extraembryonic_tissu | 1.33550638 |
| 40 | MP0005076_abnormal_cell_differentiation | 1.31572781 |
| 41 | * MP0003984_embryonic_growth_retardation | 1.30241258 |
| 42 | MP0004197_abnormal_fetal_growth/weight/ | 1.30234824 |
| 43 | * MP0002088_abnormal_embryonic_growth/wei | 1.28141996 |
| 44 | * MP0002085_abnormal_embryonic_tissue | 1.27611733 |
| 45 | MP0006292_abnormal_olfactory_placode | 1.27603219 |
| 46 | MP0002796_impaired_skin_barrier | 1.27314975 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.22109757 |
| 48 | MP0004233_abnormal_muscle_weight | 1.19359667 |
| 49 | MP0005360_urolithiasis | 1.19109680 |
| 50 | MP0002234_abnormal_pharynx_morphology | 1.17782131 |
| 51 | MP0003941_abnormal_skin_development | 1.17419233 |
| 52 | MP0010030_abnormal_orbit_morphology | 1.17241831 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.16600340 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.16574556 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.16574556 |
| 56 | MP0002722_abnormal_immune_system | 1.15817906 |
| 57 | MP0005266_abnormal_metabolism | 1.15718823 |
| 58 | MP0003567_abnormal_fetal_cardiomyocyte | 1.15622443 |
| 59 | MP0002398_abnormal_bone_marrow | 1.15577980 |
| 60 | MP0003315_abnormal_perineum_morphology | 1.15462023 |
| 61 | MP0004147_increased_porphyrin_level | 1.12947966 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.12136208 |
| 63 | MP0002084_abnormal_developmental_patter | 1.11343015 |
| 64 | MP0000358_abnormal_cell_content/ | 1.11105365 |
| 65 | MP0000477_abnormal_intestine_morphology | 1.09277166 |
| 66 | MP0001727_abnormal_embryo_implantation | 1.02188971 |
| 67 | MP0008995_early_reproductive_senescence | 1.00115807 |
| 68 | MP0004133_heterotaxia | 0.99599739 |
| 69 | MP0001145_abnormal_male_reproductive | 0.98814045 |
| 70 | MP0002429_abnormal_blood_cell | 0.97783344 |
| 71 | MP0005085_abnormal_gallbladder_physiolo | 0.95327670 |
| 72 | MP0001881_abnormal_mammary_gland | 0.94608141 |
| 73 | MP0001849_ear_inflammation | 0.94432075 |
| 74 | MP0002210_abnormal_sex_determination | 0.93982428 |
| 75 | MP0000750_abnormal_muscle_regeneration | 0.92975281 |
| 76 | MP0000598_abnormal_liver_morphology | 0.92177070 |
| 77 | MP0001661_extended_life_span | 0.90582284 |
| 78 | MP0005220_abnormal_exocrine_pancreas | 0.90149896 |
| 79 | MP0002139_abnormal_hepatobiliary_system | 0.89897490 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89595244 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.88834879 |
| 82 | MP0006035_abnormal_mitochondrial_morpho | 0.88777322 |
| 83 | MP0010155_abnormal_intestine_physiology | 0.88717916 |
| 84 | MP0001293_anophthalmia | 0.88303013 |
| 85 | MP0000858_altered_metastatic_potential | 0.87862757 |
| 86 | MP0001873_stomach_inflammation | 0.87194642 |
| 87 | MP0009053_abnormal_anal_canal | 0.84711508 |
| 88 | MP0001764_abnormal_homeostasis | 0.84531973 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 0.84149205 |
| 90 | MP0002697_abnormal_eye_size | 0.83889040 |
| 91 | MP0010234_abnormal_vibrissa_follicle | 0.83237066 |
| 92 | MP0005023_abnormal_wound_healing | 0.82834574 |
| 93 | MP0002009_preneoplasia | 0.82707481 |
| 94 | MP0000716_abnormal_immune_system | 0.81724032 |
| 95 | MP0005365_abnormal_bile_salt | 0.81384870 |
| 96 | MP0003866_abnormal_defecation | 0.80682403 |
| 97 | MP0000685_abnormal_immune_system | 0.80431846 |
| 98 | MP0005621_abnormal_cell_physiology | 0.80353061 |
| 99 | MP0000537_abnormal_urethra_morphology | 0.76972116 |
| 100 | MP0000653_abnormal_sex_gland | 0.76429907 |
| 101 | MP0002132_abnormal_respiratory_system | 0.75836597 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.73253428 |
| 103 | MP0002160_abnormal_reproductive_system | 0.73108945 |
| 104 | MP0001800_abnormal_humoral_immune | 0.72966308 |
| 105 | MP0005379_endocrine/exocrine_gland_phen | 0.72654555 |
| 106 | MP0003937_abnormal_limbs/digits/tail_de | 0.72311927 |
| 107 | MP0002249_abnormal_larynx_morphology | 0.71964797 |
| 108 | MP0005083_abnormal_biliary_tract | 0.71790921 |
| 109 | MP0003699_abnormal_female_reproductive | 0.71275215 |
| 110 | MP0002111_abnormal_tail_morphology | 0.71235898 |
| 111 | MP0000609_abnormal_liver_physiology | 0.70212717 |
| 112 | MP0009672_abnormal_birth_weight | 0.69702411 |
| 113 | MP0001929_abnormal_gametogenesis | 0.69057415 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.68772269 |
| 115 | MP0005501_abnormal_skin_physiology | 0.67772507 |
| 116 | MP0001853_heart_inflammation | 0.67358185 |
| 117 | MP0005389_reproductive_system_phenotype | 0.66993074 |
| 118 | MP0003385_abnormal_body_wall | 0.66201944 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.66121770 |
| 120 | MP0004264_abnormal_extraembryonic_tissu | 0.64313665 |
| 121 | MP0000371_diluted_coat_color | 0.63871009 |
| 122 | MP0001119_abnormal_female_reproductive | 0.62988588 |
| 123 | MP0005384_cellular_phenotype | 0.60876210 |
| 124 | MP0002638_abnormal_pupillary_reflex | 0.60582092 |
| 125 | MP0003890_abnormal_embryonic-extraembry | 0.60141177 |
| 126 | MP0002420_abnormal_adaptive_immunity | 0.59837301 |
| 127 | MP0005376_homeostasis/metabolism_phenot | 0.59660834 |
| 128 | MP0008873_increased_physiological_sensi | 0.59193151 |
| 129 | MP0001819_abnormal_immune_cell | 0.58880831 |
| 130 | MP0005075_abnormal_melanosome_morpholog | 0.58625467 |
| 131 | MP0000428_abnormal_craniofacial_morphol | 0.58421129 |
| 132 | MP0005671_abnormal_response_to | 0.58268444 |
| 133 | MP0009703_decreased_birth_body | 0.57577586 |
| 134 | MP0002092_abnormal_eye_morphology | 0.57041797 |
| 135 | MP0003943_abnormal_hepatobiliary_system | 0.56311753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.97914223 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.64259450 |
| 3 | Reticulocytopenia (HP:0001896) | 5.49812866 |
| 4 | Birth length less than 3rd percentile (HP:0003561) | 4.38182166 |
| 5 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.34568806 |
| 6 | Macrocytic anemia (HP:0001972) | 4.16524471 |
| 7 | Chromsome breakage (HP:0040012) | 4.08604019 |
| 8 | Pallor (HP:0000980) | 3.82437209 |
| 9 | Breast hypoplasia (HP:0003187) | 3.67990393 |
| 10 | Oral leukoplakia (HP:0002745) | 3.67882525 |
| 11 | Rough bone trabeculation (HP:0100670) | 3.37538496 |
| 12 | Multiple enchondromatosis (HP:0005701) | 3.32624373 |
| 13 | Aplastic anemia (HP:0001915) | 3.19028854 |
| 14 | Trismus (HP:0000211) | 3.04463637 |
| 15 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.00195320 |
| 16 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.00195320 |
| 17 | Microretrognathia (HP:0000308) | 2.96484127 |
| 18 | Hepatocellular necrosis (HP:0001404) | 2.95077673 |
| 19 | Hypobetalipoproteinemia (HP:0003563) | 2.92506260 |
| 20 | Carpal bone hypoplasia (HP:0001498) | 2.89207525 |
| 21 | Colon cancer (HP:0003003) | 2.88948532 |
| 22 | Truncus arteriosus (HP:0001660) | 2.85875417 |
| 23 | Hepatic necrosis (HP:0002605) | 2.85359197 |
| 24 | Progressive muscle weakness (HP:0003323) | 2.85040197 |
| 25 | Progressive external ophthalmoplegia (HP:0000590) | 2.84056275 |
| 26 | Increased serum lactate (HP:0002151) | 2.74909378 |
| 27 | Degeneration of anterior horn cells (HP:0002398) | 2.74556275 |
| 28 | Abnormality of the anterior horn cell (HP:0006802) | 2.74556275 |
| 29 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.68205962 |
| 30 | Cerebral hypomyelination (HP:0006808) | 2.60996407 |
| 31 | Mitochondrial inheritance (HP:0001427) | 2.60891440 |
| 32 | Increased CSF lactate (HP:0002490) | 2.57410917 |
| 33 | Acute necrotizing encephalopathy (HP:0006965) | 2.54081106 |
| 34 | Respiratory difficulties (HP:0002880) | 2.45135286 |
| 35 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.43577576 |
| 36 | 11 pairs of ribs (HP:0000878) | 2.41291908 |
| 37 | Absent thumb (HP:0009777) | 2.40085636 |
| 38 | Abnormal trabecular bone morphology (HP:0100671) | 2.40055208 |
| 39 | Type I transferrin isoform profile (HP:0003642) | 2.39198503 |
| 40 | Abnormality of reticulocytes (HP:0004312) | 2.38803190 |
| 41 | Premature ovarian failure (HP:0008209) | 2.37777047 |
| 42 | Short middle phalanx of the 5th finger (HP:0004220) | 2.37041759 |
| 43 | Ependymoma (HP:0002888) | 2.33388295 |
| 44 | Thrombocytosis (HP:0001894) | 2.32257520 |
| 45 | Rhabdomyosarcoma (HP:0002859) | 2.31391971 |
| 46 | Patellar aplasia (HP:0006443) | 2.30076112 |
| 47 | Microvesicular hepatic steatosis (HP:0001414) | 2.29571246 |
| 48 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.28508119 |
| 49 | Septate vagina (HP:0001153) | 2.28381703 |
| 50 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.28107126 |
| 51 | Acute encephalopathy (HP:0006846) | 2.28071473 |
| 52 | Abnormal hemoglobin (HP:0011902) | 2.27978729 |
| 53 | Hyperthyroidism (HP:0000836) | 2.26121923 |
| 54 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.25306328 |
| 55 | Hypertensive crisis (HP:0100735) | 2.24417168 |
| 56 | Petechiae (HP:0000967) | 2.24322464 |
| 57 | Squamous cell carcinoma (HP:0002860) | 2.23399902 |
| 58 | Selective tooth agenesis (HP:0001592) | 2.18720136 |
| 59 | Lipid accumulation in hepatocytes (HP:0006561) | 2.18615710 |
| 60 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.16095855 |
| 61 | IgM deficiency (HP:0002850) | 2.14312015 |
| 62 | Cleft eyelid (HP:0000625) | 2.12341008 |
| 63 | Dicarboxylic aciduria (HP:0003215) | 2.11888331 |
| 64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.11888331 |
| 65 | Renal Fanconi syndrome (HP:0001994) | 2.10723146 |
| 66 | Acute myeloid leukemia (HP:0004808) | 2.10131656 |
| 67 | Cerebral edema (HP:0002181) | 2.09623720 |
| 68 | Increased hepatocellular lipid droplets (HP:0006565) | 2.09409889 |
| 69 | Abnormal number of incisors (HP:0011064) | 2.09193624 |
| 70 | Lactic acidosis (HP:0003128) | 2.09099144 |
| 71 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.09049675 |
| 72 | Rectal prolapse (HP:0002035) | 2.08749777 |
| 73 | Neoplasm of the pancreas (HP:0002894) | 2.08644593 |
| 74 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.08216689 |
| 75 | Premature graying of hair (HP:0002216) | 2.06295333 |
| 76 | Seborrheic dermatitis (HP:0001051) | 2.04132638 |
| 77 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.03970967 |
| 78 | Cellular immunodeficiency (HP:0005374) | 2.03799971 |
| 79 | Abnormality of chromosome stability (HP:0003220) | 2.03226344 |
| 80 | Sparse lateral eyebrow (HP:0005338) | 2.02468420 |
| 81 | Pancytopenia (HP:0001876) | 2.02019706 |
| 82 | Abnormality of cochlea (HP:0000375) | 2.01274865 |
| 83 | CNS demyelination (HP:0007305) | 2.00441373 |
| 84 | Lethargy (HP:0001254) | 2.00360179 |
| 85 | Basal cell carcinoma (HP:0002671) | 1.99359229 |
| 86 | Secondary amenorrhea (HP:0000869) | 1.98937920 |
| 87 | Hypoparathyroidism (HP:0000829) | 1.98578996 |
| 88 | Abnormality of the tricuspid valve (HP:0001702) | 1.97204026 |
| 89 | Horseshoe kidney (HP:0000085) | 1.96684177 |
| 90 | Hypergonadotropic hypogonadism (HP:0000815) | 1.95639762 |
| 91 | Increased serum pyruvate (HP:0003542) | 1.95114414 |
| 92 | Sparse eyelashes (HP:0000653) | 1.93935540 |
| 93 | Poikiloderma (HP:0001029) | 1.93440748 |
| 94 | Triphalangeal thumb (HP:0001199) | 1.92049835 |
| 95 | Cutaneous melanoma (HP:0012056) | 1.91176419 |
| 96 | Respiratory failure (HP:0002878) | 1.91079067 |
| 97 | Acute lymphatic leukemia (HP:0006721) | 1.90471420 |
| 98 | Redundant skin (HP:0001582) | 1.90251673 |
| 99 | Meckel diverticulum (HP:0002245) | 1.89302619 |
| 100 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.87794959 |
| 101 | Emotional lability (HP:0000712) | 1.87594039 |
| 102 | Reticulocytosis (HP:0001923) | 1.87420998 |
| 103 | Megaloblastic anemia (HP:0001889) | 1.86888034 |
| 104 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.86258452 |
| 105 | Abnormality of homocysteine metabolism (HP:0010919) | 1.85874784 |
| 106 | Homocystinuria (HP:0002156) | 1.85874784 |
| 107 | Angiofibromas (HP:0010615) | 1.84673369 |
| 108 | Adenoma sebaceum (HP:0009720) | 1.84673369 |
| 109 | Abnormality of glycolysis (HP:0004366) | 1.83891129 |
| 110 | Abnormality of the preputium (HP:0100587) | 1.83163985 |
| 111 | Increased nuchal translucency (HP:0010880) | 1.82645730 |
| 112 | Overlapping toe (HP:0001845) | 1.82456073 |
| 113 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.82388453 |
| 114 | Increased intramyocellular lipid droplets (HP:0012240) | 1.82315492 |
| 115 | Medulloblastoma (HP:0002885) | 1.82313907 |
| 116 | Increased muscle lipid content (HP:0009058) | 1.82275631 |
| 117 | Ragged-red muscle fibers (HP:0003200) | 1.81933574 |
| 118 | Gout (HP:0001997) | 1.81758874 |
| 119 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.80107250 |
| 120 | Diastasis recti (HP:0001540) | 1.79398502 |
| 121 | Abnormality of methionine metabolism (HP:0010901) | 1.79249241 |
| 122 | Absent radius (HP:0003974) | 1.78630220 |
| 123 | Progressive macrocephaly (HP:0004481) | 1.77589589 |
| 124 | Agnosia (HP:0010524) | 1.77174753 |
| 125 | Male infertility (HP:0003251) | 1.77022736 |
| 126 | Myelodysplasia (HP:0002863) | 1.75578367 |
| 127 | Self-mutilation (HP:0000742) | 1.75552422 |
| 128 | Abnormal protein glycosylation (HP:0012346) | 1.75461495 |
| 129 | Abnormal glycosylation (HP:0012345) | 1.75461495 |
| 130 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.75461495 |
| 131 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.75461495 |
| 132 | Death in infancy (HP:0001522) | 1.73888784 |
| 133 | Abnormality of the ileum (HP:0001549) | 1.73575402 |
| 134 | Bone marrow hypocellularity (HP:0005528) | 1.73493589 |
| 135 | Orthostatic hypotension (HP:0001278) | 1.73336003 |
| 136 | Missing ribs (HP:0000921) | 1.73243688 |
| 137 | Lymphoma (HP:0002665) | 1.71292695 |
| 138 | Depressed nasal ridge (HP:0000457) | 1.70726256 |
| 139 | Double outlet right ventricle (HP:0001719) | 1.70291321 |
| 140 | Congenital malformation of the right heart (HP:0011723) | 1.70291321 |
| 141 | Abnormal cartilage morphology (HP:0002763) | 1.70222595 |
| 142 | Exercise intolerance (HP:0003546) | 1.69896046 |
| 143 | Hypolipoproteinemia (HP:0010981) | 1.69337068 |
| 144 | Reduced antithrombin III activity (HP:0001976) | 1.68163847 |
| 145 | Testicular atrophy (HP:0000029) | 1.67479216 |
| 146 | Atresia of the external auditory canal (HP:0000413) | 1.67376454 |
| 147 | Embryonal renal neoplasm (HP:0011794) | 1.66823795 |
| 148 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.65840786 |
| 149 | Villous atrophy (HP:0011473) | 1.65840786 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.01801609 |
| 2 | WEE1 | 3.84601666 |
| 3 | BUB1 | 3.69181387 |
| 4 | STK16 | 3.42287662 |
| 5 | CDC7 | 3.07780328 |
| 6 | TESK2 | 2.87910204 |
| 7 | SMG1 | 2.60552118 |
| 8 | EIF2AK1 | 2.47860911 |
| 9 | VRK2 | 2.40641298 |
| 10 | TLK1 | 2.24481259 |
| 11 | PBK | 2.19674212 |
| 12 | NEK2 | 2.15591190 |
| 13 | ACVR1B | 2.08929017 |
| 14 | TAF1 | 2.02522543 |
| 15 | DYRK3 | 2.02425942 |
| 16 | RPS6KB2 | 1.97363670 |
| 17 | SRPK1 | 1.94578229 |
| 18 | PIM2 | 1.91838238 |
| 19 | KDR | 1.79586670 |
| 20 | PLK1 | 1.66693339 |
| 21 | SCYL2 | 1.66421779 |
| 22 | VRK1 | 1.66354268 |
| 23 | TRIB3 | 1.61932007 |
| 24 | BRSK2 | 1.60648328 |
| 25 | EIF2AK3 | 1.60312889 |
| 26 | TSSK6 | 1.59383493 |
| 27 | EPHA2 | 1.57374671 |
| 28 | TTK | 1.50306383 |
| 29 | NEK1 | 1.49168179 |
| 30 | AURKB | 1.48085488 |
| 31 | CDK7 | 1.47674105 |
| 32 | BRAF | 1.44972408 |
| 33 | PASK | 1.42923384 |
| 34 | MAP3K8 | 1.41795592 |
| 35 | MAPKAPK3 | 1.39886162 |
| 36 | PLK4 | 1.38137670 |
| 37 | AURKA | 1.37518086 |
| 38 | ICK | 1.37126825 |
| 39 | ERN1 | 1.35058723 |
| 40 | MKNK1 | 1.34490049 |
| 41 | BCKDK | 1.33544097 |
| 42 | EEF2K | 1.27434719 |
| 43 | FLT3 | 1.22139623 |
| 44 | STK10 | 1.20246848 |
| 45 | PAK4 | 1.20043528 |
| 46 | MKNK2 | 1.20032106 |
| 47 | MAP2K2 | 1.18368459 |
| 48 | MAP4K1 | 1.17669112 |
| 49 | MATK | 1.16765496 |
| 50 | RPS6KA4 | 1.15559199 |
| 51 | PRPF4B | 1.10691063 |
| 52 | PRKG2 | 1.08612890 |
| 53 | DDR2 | 1.08607601 |
| 54 | CLK1 | 1.06120585 |
| 55 | MAP3K10 | 1.05134794 |
| 56 | LRRK2 | 1.04655139 |
| 57 | PDK2 | 1.04222448 |
| 58 | ATR | 1.02833987 |
| 59 | TGFBR1 | 1.02309970 |
| 60 | MAP3K11 | 0.99648047 |
| 61 | TESK1 | 0.97770383 |
| 62 | CDK4 | 0.93921226 |
| 63 | KSR2 | 0.93117369 |
| 64 | PIM1 | 0.91967817 |
| 65 | CHEK2 | 0.90982091 |
| 66 | PKN2 | 0.88445290 |
| 67 | NME1 | 0.86498181 |
| 68 | CDK8 | 0.86108176 |
| 69 | RAF1 | 0.86013929 |
| 70 | BRSK1 | 0.82673597 |
| 71 | ZAP70 | 0.82310567 |
| 72 | CSNK2A2 | 0.75670386 |
| 73 | GRK6 | 0.73458810 |
| 74 | CHEK1 | 0.72159159 |
| 75 | IRAK2 | 0.71426353 |
| 76 | PLK3 | 0.70312218 |
| 77 | PRKCI | 0.66921694 |
| 78 | ALK | 0.66292272 |
| 79 | DYRK2 | 0.64308660 |
| 80 | CSNK2A1 | 0.63572106 |
| 81 | LATS2 | 0.63236790 |
| 82 | ZAK | 0.62916670 |
| 83 | MST4 | 0.62628545 |
| 84 | CCNB1 | 0.62324380 |
| 85 | AKT2 | 0.62082499 |
| 86 | BRD4 | 0.61052559 |
| 87 | RPS6KA5 | 0.60041312 |
| 88 | CDK12 | 0.59696048 |
| 89 | PAK1 | 0.55355815 |
| 90 | CDK2 | 0.54570510 |
| 91 | ABL2 | 0.54497948 |
| 92 | LIMK1 | 0.53835549 |
| 93 | EIF2AK2 | 0.52719641 |
| 94 | NUAK1 | 0.52092401 |
| 95 | ARAF | 0.51369559 |
| 96 | CDK9 | 0.50501607 |
| 97 | ATM | 0.48079286 |
| 98 | TEC | 0.47008049 |
| 99 | CDK19 | 0.45808758 |
| 100 | MAP3K2 | 0.45563354 |
| 101 | MAPK11 | 0.45421922 |
| 102 | MAP3K1 | 0.45127508 |
| 103 | STK3 | 0.43449253 |
| 104 | DAPK3 | 0.42936173 |
| 105 | MTOR | 0.41976602 |
| 106 | MAP3K13 | 0.41232377 |
| 107 | IRAK4 | 0.40024352 |
| 108 | MAP3K3 | 0.38767539 |
| 109 | CDK6 | 0.38697046 |
| 110 | PAK2 | 0.37944520 |
| 111 | MAP3K14 | 0.37483319 |
| 112 | DYRK1B | 0.36994810 |
| 113 | STK4 | 0.36560031 |
| 114 | STK24 | 0.36264777 |
| 115 | JAK3 | 0.34060047 |
| 116 | MAP2K3 | 0.31800001 |
| 117 | ILK | 0.31653948 |
| 118 | MELK | 0.31098450 |
| 119 | CDK1 | 0.30234625 |
| 120 | CSNK1E | 0.29866750 |
| 121 | NEK9 | 0.29434264 |
| 122 | BTK | 0.29194982 |
| 123 | NLK | 0.28450595 |
| 124 | MAPK14 | 0.28106381 |
| 125 | TAOK2 | 0.27452413 |
| 126 | KIT | 0.26990062 |
| 127 | IRAK3 | 0.26913919 |
| 128 | MOS | 0.26135145 |
| 129 | CSK | 0.26117887 |
| 130 | LYN | 0.23909103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.07534443 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.28728362 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.58667013 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.35577998 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.28654228 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 3.06143005 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.80377494 |
| 8 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.52225041 |
| 9 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.49013375 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.47080841 |
| 11 | RNA transport_Homo sapiens_hsa03013 | 2.42450320 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 2.35692766 |
| 13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.31106342 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.15377033 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 2.06154281 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 1.83686787 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.75852929 |
| 18 | RNA degradation_Homo sapiens_hsa03018 | 1.46749501 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.46566249 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.44654924 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.42839760 |
| 22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.42699536 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.37564024 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29660739 |
| 25 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.28093951 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.26610103 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25245997 |
| 28 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.24530967 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.22871186 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.20071374 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.16952846 |
| 32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14417059 |
| 33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13154379 |
| 34 | Huntingtons disease_Homo sapiens_hsa05016 | 1.09811362 |
| 35 | Purine metabolism_Homo sapiens_hsa00230 | 1.09032572 |
| 36 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.06477147 |
| 37 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.04531756 |
| 38 | Protein export_Homo sapiens_hsa03060 | 1.03662604 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00227192 |
| 40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.98298863 |
| 41 | Thyroid cancer_Homo sapiens_hsa05216 | 0.97767362 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97601651 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96746958 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.94616577 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.91390140 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91178956 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88227737 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86856019 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85193279 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.82420754 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80159836 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.79161820 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78382044 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77646398 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.76240319 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74954276 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70249333 |
| 58 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69826779 |
| 59 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67222065 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66334627 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64738575 |
| 62 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62971343 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62542988 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62531137 |
| 65 | Bladder cancer_Homo sapiens_hsa05219 | 0.60168212 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59544038 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57844747 |
| 68 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57640928 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55890682 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55218106 |
| 71 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50117888 |
| 72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48454239 |
| 73 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46857057 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46547296 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45781763 |
| 76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40625779 |
| 77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39250227 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37243854 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.36172419 |
| 80 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.34693813 |
| 81 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33315908 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32920768 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.32767422 |
| 84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32336842 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31843008 |
| 86 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31711010 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31092222 |
| 88 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.30707105 |
| 89 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.30318098 |
| 90 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.30043559 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.28620219 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27961078 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26790056 |
| 94 | Legionellosis_Homo sapiens_hsa05134 | 0.23825176 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23766019 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.22419329 |
| 97 | Lysine degradation_Homo sapiens_hsa00310 | 0.22353898 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22229567 |
| 99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21920812 |
| 100 | Measles_Homo sapiens_hsa05162 | 0.21554431 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21035280 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.20769977 |
| 103 | Retinol metabolism_Homo sapiens_hsa00830 | 0.20721590 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.20264747 |
| 105 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.19234781 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.18921095 |
| 107 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.18840790 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.18363542 |
| 109 | Melanoma_Homo sapiens_hsa05218 | 0.18014755 |
| 110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.17714502 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16344042 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.16208071 |
| 113 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.15523372 |
| 114 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.15506293 |
| 115 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.14627788 |
| 116 | Alcoholism_Homo sapiens_hsa05034 | 0.13722570 |
| 117 | Shigellosis_Homo sapiens_hsa05131 | 0.13567409 |
| 118 | Hepatitis B_Homo sapiens_hsa05161 | 0.13380837 |
| 119 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.12858542 |
| 120 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.12670104 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.12443340 |
| 122 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.12331330 |
| 123 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.11627989 |

